Publications in collaboration with researchers from Hospital Universitari de Bellvitge (74)

2024

  1. Repetitive ambulatory levosimendan as a bridge to heart transplantation

    Revista Espanola de Cardiologia, Vol. 77, Núm. 4, pp. 290-301

  2. Review of the allocation criteria for heart transplant in Spain in 2023. SEC-Heart Failure Association/ONT/SECCE consensus document

    Revista Espanola de Cardiologia, Vol. 77, Núm. 1, pp. 69-78

2023

  1. Repetitive levosimendan infusions for patients with advanced chronic heart failure in the vulnerable post-discharge period: The multinational randomized LeoDOR trial

    European Journal of Heart Failure, Vol. 25, Núm. 11, pp. 2007-2017

  2. Spanish heart transplant registry. 34th official report of the Heart Failure Association of the Spanish Society of Cardiology

    Revista Espanola de Cardiologia, Vol. 76, Núm. 11, pp. 901-909

2022

  1. Infectious complications associated with short-term mechanical circulatory support in urgent heart transplant candidates

    Revista Espanola de Cardiologia, Vol. 75, Núm. 2, pp. 141-149

  2. Spanish Heart Transplant Registry. 33rd official report of the Heart Failure Association of the Spanish Society of Cardiology

    Revista Espanola de Cardiologia, Vol. 75, Núm. 11, pp. 926-935

  3. Utility of the IMPACT score for predicting heart transplant mortality. Analysis on a contemporary cohort of the Spanish Heart Transplant Registry

    Clinical Transplantation, Vol. 36, Núm. 9

2021

  1. Consensus on improving the comprehensive care of patients with acute heart failure

    Revista Clinica Espanola, Vol. 221, Núm. 3, pp. 163-168

  2. Impact of donor-recipient age on cardiac transplant survival. Subanalysis of the Spanish Heart Transplant Registry

    Revista Espanola de Cardiologia, Vol. 74, Núm. 5, pp. 393-401

  3. Influence of Gender in Advanced Heart Failure Therapies and Outcome Following Transplantation

    Frontiers in Cardiovascular Medicine, Vol. 8

  4. Malignancy following heart transplantation: differences in incidence and prognosis between sexes – a multicenter cohort study

    Transplant International, Vol. 34, Núm. 5, pp. 882-893

  5. Modes of death in heart failure according to age, sex and left ventricular ejection fraction

    Internal and Emergency Medicine, Vol. 16, Núm. 3, pp. 643-652

  6. Sacubitril-Valsartan, Clinical Benefits and Related Mechanisms of Action in Heart Failure With Reduced Ejection Fraction. A Review

    Frontiers in Cardiovascular Medicine, Vol. 8

  7. Spanish Heart Transplant Registry. 32nd Official Report of the Heart Failure Association of the Spanish Society of Cardiology

    Revista Espanola de Cardiologia, Vol. 74, Núm. 11, pp. 962-970

2020

  1. Budget impact of ferric carboxymaltose treatment in patients with chronic heart failure and iron deficiency in Spain

    Journal of Medical Economics, Vol. 23, Núm. 12, pp. 1418-1424

  2. Cold ischemia >4 hours increases heart transplantation mortality. An analysis of the Spanish heart transplantation registry

    International Journal of Cardiology, Vol. 319, pp. 14-19

  3. Economic analysis of intermittent intravenous outpatient treatment with levosimendan in advanced heart failure in Spain

    Revista Espanola de Cardiologia, Vol. 73, Núm. 5, pp. 361-367

  4. Gender differences in heart transplantation: Twenty-five year trends in the nationwide Spanish heart transplant registry

    Clinical Transplantation, Vol. 34, Núm. 12

  5. Hyperkalemia in heart failure patients in Spain and its impact on guidelines and recommendations: ESC-EORP-HFA Heart Failure Long-Term Registry

    Revista Espanola de Cardiologia, Vol. 73, Núm. 4, pp. 313-323

  6. Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use

    Journal of cardiovascular pharmacology, Vol. 76, Núm. 1, pp. 4-22